Possible Bearish Signals With Merit Medical Systems Insiders Disposing Stock
Possible Bearish Signals With Merit Medical Systems Insiders Disposing Stock
Merit Medical Systems, Inc. (NASDAQ:MMSI) shareholders may have reason to be concerned, as several insiders sold their shares over the past year. Knowing whether insiders are buying is usually more helpful when evaluating insider transactions, as insider selling can have various explanations. However, if numerous insiders are selling, shareholders should investigate more.
Merit Medical Systems, Inc.（納斯達克股票代碼：MMSI）的股東可能有理由擔心，因爲在過去的一年中，有幾位內部人士出售了股票。在評估內幕交易時，了解內部人士是否在買入通常更有幫助，因爲內幕賣出可以有多種解釋。但是，如果有許多內部人士出售，股東應該進行更多調查。
While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we would consider it foolish to ignore insider transactions altogether.
儘管我們絕不會建議投資者僅根據公司董事的所作所爲做出決定，但我們認爲完全忽視內幕交易是愚蠢的。
Merit Medical Systems Insider Transactions Over The Last Year
Merit Medical Systems 去年內幕交易
Over the last year, we can see that the biggest insider sale was by the CFO & Treasurer, Raul Parra, for US$479k worth of shares, at about US$74.52 per share. So it's clear an insider wanted to take some cash off the table, even below the current price of US$81.34. We generally consider it a negative if insiders have been selling, especially if they did so below the current price, because it implies that they considered a lower price to be reasonable. While insider selling is not a positive sign, we can't be sure if it does mean insiders think the shares are fully valued, so it's only a weak sign. It is worth noting that this sale was only 46% of Raul Parra's holding.
在過去的一年中，我們可以看到，最大的內幕出售是首席財務官兼財務主管勞爾·帕拉，以每股約74.52美元的價格出售了價值47.9萬美元的股票。因此，很明顯，一位內部人士想從桌上提取一些現金，甚至低於目前的81.34美元。如果內部人士一直在賣出，特別是如果他們賣出低於當前價格，我們通常認爲這是負面的，因爲這意味着他們認爲較低的價格是合理的。儘管內幕拋售不是一個積極的信號，但我們無法確定這是否意味着內部人士認爲股票已完全估值，因此這只是一個弱勢信號。值得注意的是，此次出售僅佔勞爾·帕拉持股量的46％。
In the last year Merit Medical Systems insiders didn't buy any company stock. The chart below shows insider transactions (by companies and individuals) over the last year. By clicking on the graph below, you can see the precise details of each insider transaction!
去年，Merit Medical Systems的內部人士沒有購買任何公司股票。下圖顯示了去年的內幕交易（公司和個人）。通過點擊下面的圖表，你可以看到每筆內幕交易的確切細節！
For those who like to find hidden gems this free list of small cap companies with recent insider purchasing, could be just the ticket.
對於那些喜歡尋找隱藏寶石的人來說，這份最近有內幕收購的小盤股公司的免費清單可能就是門票。
Insider Ownership Of Merit Medical Systems
Merit 醫療系統的內部所有權
Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Merit Medical Systems insiders own about US$110m worth of shares (which is 2.3% of the company). Most shareholders would be happy to see this sort of insider ownership, since it suggests that management incentives are well aligned with other shareholders.
查看公司的內部持股總量可以幫助你了解他們是否與普通股股東保持一致。通常，內部人士的所有權越高，內部人士長期建立公司的可能性就越大。Merit Medical Systems內部人士擁有價值約1.1億美元的股份（佔該公司的2.3％）。大多數股東會很高興看到這種內部所有權，因爲這表明管理層的激勵措施與其他股東非常一致。
So What Do The Merit Medical Systems Insider Transactions Indicate?
那麼，Merit Medical Systems的內幕交易表明了什麼？
There haven't been any insider transactions in the last three months -- that doesn't mean much. It's heartening that insiders own plenty of stock, but we'd like to see more insider buying, since the last year of Merit Medical Systems insider transactions don't fill us with confidence. If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future.
在過去的三個月中，沒有任何內幕交易——這並不意味着什麼。內部人士擁有大量股票令人鼓舞，但我們希望看到更多的內幕買盤，因爲去年的Merit Medical Systems內幕交易並沒有使我們充滿信心。如果你像我一樣，你可能需要考慮這家公司是增長還是萎縮。幸運的是，您可以查看這份免費報告，該報告顯示了分析師對其未來的預測。
Of course Merit Medical Systems may not be the best stock to buy. So you may wish to see this free collection of high quality companies.
當然，Merit Medical Systems可能不是最好的買入股票。因此，您可能希望看到這個免費的高質量公司集合。
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
就本文而言，內部人士是指向相關監管機構報告其交易的個人。我們目前只考慮公開市場交易和私下處置的直接利益，不包括衍生品交易或間接權益。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對這篇文章有反饋嗎？對內容感到擔憂？直接聯繫我們。 或者，給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論，我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議，也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意，我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之，華爾街沒有持有任何上述股票的頭寸。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
對這篇文章有反饋嗎？對內容感到擔憂？直接聯繫我們。 或者，發送電子郵件至 editorial-team@simplywallst.com
譯文內容由第三人軟體翻譯。